Review article: managing the adverse events caused by anti‐TNF therapy in inflammatory bowel disease
Uday N. Shivaji(National Institute for Health and Care Research), Neeraj Bhala(NIHR Surgical Reconstruction and Microbiology Research Centre), C Sharratt(Nottingham University Hospitals NHS Trust), Gordon W. Moran(Nottingham University Hospitals NHS Trust), Marietta Iacucci(University Hospitals Birmingham NHS Foundation Trust), Tom Thomas(Nuffield Orthopaedic Centre), Subrata Ghosh(University College Cork), Samuel C. Smith(The Edgbaston Hospital)
Cited by 155
Related Papers
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
Surface topography as a nonstationary random process
|Nature|1978|696
Fibroblasts as immune regulators in infection, inflammation and cancer
|Nature reviews. Immunology|2021|597
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558